AD/PD™ 2026

GemPharmatech will be attending AD/PD™ 2026, where we look forward to engaging with the neuroscience research community to discuss advanced preclinical solutions for neurodegenerative disease studies.

Our integrated platforms are designed to support mechanistic research, drug efficacy evaluation, and translational development across Alzheimer’s disease, Parkinson’s disease, and related neurological disorders.

• Time: March 17–21, 2026 

• Location: Bella Center Copenhagen, Copenhagen, Denmark 

Join us at Booth #76 and connect with our team members, including Dr. Brandy Wilkinson, Dr. Rikki Feng, Oliver Dong and Elaine Rong. They will be ready to walk you through the data, learn about your projects, and explore how our neuroscience research platform can help accelerate your discoveries.

Poster Presentations

Construction And Pharmacological Evaluation Of A New Parkinson’s Disease Mouse Model

• Time: March 17, 07:30 a.m. – March 19, 12:00 p.m.

• Board #: SHIFT 01-007

 Listen to the poster overview [Audio Only]

Download Poster →

Unveiling FAD3T: A Groundbreaking Transgenic Mouse Model for Accelerating Alzheimer’s Disease Research

• Time: March 17, 07:30 a.m. – March 19, 12:00 p.m.

• Board #: SHIFT 01-603

 Listen to the poster overview [Audio Only]

Download Poster →

Let’s Connect in Advance

Schedule a meeting with us to discuss how our integrated preclinical solutions can support your research and drug development programs.

Email: sales@gempharmatech.com

Contact Us →

Our Neurological Capabilities

• Comprehensive suite of behavioral testing services

• In vivo drug efficacy evaluation platforms

• End-to-end study design and execution strategies

• Mechanistic research support for CNS disorders

Learn More →